Smruthi Organics receives warning letter from USFDA for Solapur plant

18 Mar 2014 Evaluate

Smruthi Organics has received a warning letter from the United States Food & Drugs Administration (USFDA) for its site located at A-27, MIDC Chincholi, Solapur in state of Maharashtra with reference to the observations of inspection performed in October, 2013. The company is working with USFDA in resolving the issues.

Smruthi Organics is a mid-size, public limited, API manufacturing company from Solapur, India. The company has been part of successful contract manufacturing and custom synthesis agreements with leading European, American and Japanese customers.

Smruthi Organics Share Price

121.15 0.95 (0.79%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×